Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Plasmodium falciparum Niemann-Pick type C1-related protein (PfNCR1) is an essential membrane transporter localized to the plasma membrane of the malaria parasite Plasmodium falciparum. It plays a critical role in maintaining membrane lipid composition, particularly by shuttling cholesterol between different compartments within the parasite. Structural studies have revealed that PfNCR1 contains distinct binding sites for cholesterol and forms a tunnel-like structure facilitating its export from the parasite plasma membrane to the parasitophorous vacuole, which is vital for parasite survival during its asexual blood stage. PfNCR1 has been validated as a druggable antimalarial target. Inhibitors such as MMV009108 block this transporter, leading to disruption of membrane homeostasis and increased sensitivity of parasites to saponin—ultimately resulting in their death. The essentiality and lack of close human orthologs make it an attractive candidate for therapeutic intervention against malaria.
Inhibition of PfNCR1 blocks cholesterol transport and disrupts membrane homeostasis in the parasite
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium falciparum Niemann-Pick type C1-related protein (PfNCR1).